John D. Livingstone, Partner, Finnegan, Henderson, Farabow, Garrett & Dunner, LLP, U.S. District Court, N.D. Georgia U.S. Court of Appeals, Eleventh Circuit U.S. Court of Appeals, Federal Circuit U.S. Patent and Trademark Office
John Livingstone’s practice focuses on U.S. district court patent litigation involving the pharmaceutical, chemical, and biotechnology arts. He has a broad range of litigation experience representing patent owners as well as accused infringers in all phases and types of litigation, including patent, trade secret misappropriation, trademark, and copyright litigation. Mr. Livingstone provides strategic portfolio management and litigation counseling to both foreign and domestic clients and evaluates corporate patent portfolios in connection with mergers and acquisitions and in-licensing opportunities. He also provides opinions on patent infringement, validity, and enforceability, often as a prelude to infringement litigation. In addition, Mr. Livingstone advises clients on developing effective patent portfolios, addressing specific prosecution problems, and creating targeted claim strategies with an eye toward future litigation.
The Effect of Recent U.S. Supreme Court Rulings on Diagnostics and Precision Medicine Patents
Thursday, 1 December 2016 at 14:45
This presentation will focus on developments in United States patent practice. Specifically, it will focus on recent Supreme Court decisions and their effect on the patenting and enforcement of diagnostic technologies and personalized medicine, including patent subject matter eligibility and indirect infringement. The presentation will address these recent trends with a focus on the practical implications of these developments to your everyday practice.